This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Congestive heart failure
  • /
  • New role of ventricular assist devices as bridge t...
Journal

New role of ventricular assist devices as bridge to transplantation: European perspective.

Read time: 1 mins
Published:1st Jun 2017
Author: Reineke DC, Mohacsi PJ.
Availability: Free full text
Ref.:Curr Opin Organ Transplant. 2017 Jun;22(3):225-230.
DOI:10.1097/MOT.0000000000000412.

PURPOSE OF REVIEW:

Progress of ventricular assist devices (VAD) technology led to improved survival and apparently low morbidity. However, from the European perspective, updated analysis of EUROMACS reveals a somewhat less impressive picture with respect to mortality and morbidity.

RECENT FINDINGS:

We describe the great demand of cardiac allografts versus the lack of donors, which is larger in Europe than in the United States. Technical progress of VADs made it possible to work out a modern algorithm of bridge-to-transplant, which is tailored to the need of the particular patient. We analyze the burden of patients undergoing bridge-to-transplant therapy. They are condemned to an intermediate step, coupled with additional major surgery and potential adverse events during heart transplantation.

SUMMARY:

Based on current registry data, we do have to question the increasingly popular opinion, that the concept of heart transplantation is futureless, which seems to be for someone who treats and compares both patients (VAD and heart transplantation) in daily practice, questionable. Up to now, left ventricular assist device therapy remains a bridge to a better future, which means a bridge to technical innovations or to overcome the dramatic lack of donors in Europe.

 

Read abstract on library site

Access full article